Michael Kagey

Michael Kagey

Company: Leap Therapeutics

Job title: Senior Director of Translational Medicine

Seminars:

Developing a DKK1 RNAscope Biomarker Assay for DKN-01 Patient Stratification 3:30 pm

• Justifying the mechanistic rationale for neutralising DKK1 in oncology • Delving into the development of a DKK1 RNAscope biomarker assay • Sharing results from Leap Therapeutics’ DisTinGuish clinical trialRead more

day: Track A - Day 1 pm

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.